Queen Creek, Arizona — The Arizona Attorney General's Office announced that its statewide naloxone distribution initiative has surpassed major operational milestones, supplying more than 110,000 doses of the overdose-reversal medication to public agencies and community organizations across the state.
Participating healthcare providers, first responders, and emergency shelters have documented at least 500 successful overdose reversals through the distributed medication, with several grassroots service providers recording as many as twelve life-saving interventions in a single day. The supplies are funded through opioid settlement agreements negotiated with major pharmaceutical manufacturers and wholesale distributors.
State prosecutors emphasized that delivering overdose-reversal supplies directly to frontline responders, shelter personnel, healthcare workers, and educators provides crucial opportunities to save lives and support vulnerable community members facing substance emergencies.
Over the past two years, initial shipments totaling 55,442 twin-dose units reached recipient organizations across thirteen Arizona counties, including public health entities, regional school districts, and tribal communities such as the Hopi Nation. Scheduled commitments for 2026 include 27,721 units from Teva Pharmaceuticals, an anticipated 6,599 units from Hikma Pharmaceuticals, and an initial 8,428 units ordered this September from Amneal Pharmaceuticals.
